Safety and efficacy of adalimumab (D2E7) in Crohn's disease patients with an attenuated response to infliximab

Konstantinos A. Papadakis, Omid A. Shaye, Eric A. Vasiliauskas, Andrew Ippoliti, Marla C. Dubinsky, Jaime Birt, Jane Paavola, Susie K. Lee, Joanne Price, Stephan R. Targan, Maria T. Abreu

Research output: Contribution to journalArticle

157 Scopus citations

Fingerprint Dive into the research topics of 'Safety and efficacy of adalimumab (D2E7) in Crohn's disease patients with an attenuated response to infliximab'. Together they form a unique fingerprint.

Medicine & Life Sciences